Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer. - Kian W; Levitas D; Alguayn W; Shalata W; Sharb AA; Levin D; Roisman LC; Tokar M; Peled N; Yakobson A (JTO clinical and research reports, 2020)